Biological Data Visualization Market Trends, Industry | 2031
Biological Data Visualization Market Trends, Industry | 2031
Segments - Biological Data Visualization Market by Techniques (Microscopy, Magnetic Resonance Imaging, Sequencing, X-ray Crystallography, and Others), Application (Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis, Alignments, Phylogeny, & Evolution, and Systems Biology), Platform (Windows, Mac OS, Linux, and Others), End-user (Academic Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Region (Asia Pacific, North America, Europe, Latin America, and Middle East &Africa) - Global Industry Analysis, Growth, Share, Trends, Size, and Forecast 2023-2031
Upcoming
| Report ID :ICT-SE-3895
| 4.4 Rating
| 79 Reviews
| 217 Pages
| Format :
Report Description
Biological Data Visualization Market Outlook 2031
The global biological data visualization market size was valued at USD 960.08 Million in 2022 and is expected to reach USD 2.10 Billion by 2031, expanding at a CAGR of 9.1% during the forecast period, 2023–2031. The market growth is attributed to the rapid advancements in biological data and their increasing demand for virtual reality platforms.
The application of scientific visualization, computer graphics, and information visualization to several areas of the life sciences is referred to as biological data visualization. Sequences, microscopy, genomes, magnetic resonance imaging, and others are examples of this. Key factors such as increased awareness among physicians and patients about the benefits of biological data visualization and high penetration of information technology are manipulating the market expansion.
The implementation of data visualization in the life science industry is paving the way for new opportunities in the market. It is an essential tool in the life science industry as biological data visualization tools help find trends and patterns that are difficult to find from raw data. Many software systems are available for the visualization of biological data such as Medusa, Cytoscape, Proviz, and PATIKA.
The Impact of Artificial Intelligence in The Biological Data Visualization Market
Artificial intelligence has a significant impact on the market as it helps accelerate existing datasets with the help of synthetic data. With the help of generative AI, large datasets are able to be compressed into files. Furthermore, it helps in identifying datasets that indicate biological phenomena. This enables researchers to perform detailed analysis of large datasets which in turn help them predict the safety and efficacy of new drugs. This results in cost-friendly and faster drug discovery leading to better patient outcomes.
The market report finds that COVID-19 has considerably impacted the market as the significance of biotechnology boosted during the pandemic. The pandemic highlighted the importance of biotechnology as the outbreak has accelerated the counts of potential vaccine candidates and generated several diagnostics. Moreover, key players are taking various strategic initiatives to tackle the disease, such as collaborations and licensing for collaborative efforts.
- For instance, in February 2021, the Canadian government invested USD 53 million to execute a multi-tiered approach to treat COVID-19. The Government of Canada is expected to use genome sequencing and analysis technologies to achieve the results.
Biological Data Visualization Market Dynamics
Major Drivers
The rapid growth of big data, combined with the huge size and complexity of biological data, has resulted in a worldwide increase in the use of visualization tools. This is expected to boost the market in the coming years. Growing demand for rapid judgments needs the use of modern analytical techniques. These variables are expected to drive the adoption rate of visualizing tools, which is anticipated to boost the market.
Existing Restraints
Issues with the user interface, as well as the lack of computational consistency for data management, are projected to restrain the growth of the biological data visualization market.
Emerging Opportunities
Rising demand for data visualization in the healthcare industry as it helps in visualizing clinical trials and allows researchers to identify trends quickly. It helps facilitate patient responses and other adverse events. The adoption of AI to transform biological data visualization by major players is expected to create opportunities for the market in the coming years.- For instance, in May 2023, Deepcell, a leader in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, launched the REM-I Platform, a high-dimensional cell morphology analysis and sorting platform that consists of the REM-I benchtop instrument, Human Foundation Model, and others. Deepcell is expected to present data on the company’s AI-based morphology profiling solutions, which benefits the company’s proprietary.
Scope of Biological Data Visualization Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Biological Data Visualization Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016-2021 |
|
Forecast Period |
2023-2031 |
|
Segmentation |
Techniques (Microscopy, Magnetic Resonance Imaging, Sequencing, X-ray Crystallography, and Others), Application (Cell and organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis, Alignments, Phylogeny, & Evolution, and Systems Biology), Platform (Windows, Mac OS, Linux, and Others), End-use (Academic Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players covered in the Report |
Thermo Fisher Scientific Inc., QIAGEN, Becton-Dickinson and Company, Agilent Technologies, Inc., 3M, Carl Zeiss AG, Oxford Instruments, Olympus Corporation, GE Healthcare, Clarivate Analytics, arivis AG, Scientific Volume Imaging B.V., Media Cybernetics, Inc., Molecular Devices, LLC, and Danaher. |
Biological Data Visualization Market Segment Insights
Techniques Segment Analysis
Based on techniques, the market is divided into microscopy, magnetic resonance imaging, sequencing, x-ray crystallography, and others. The sequencing segment is expected to account for a key share of the market during the forecast period due to the broad range of applications of next-generation sequencing (NGS) in genomes and epigenetics, systems biology, and evolutionary datasets. Moreover, rising partnerships among key players to integrate next-generation sequencing testing pipelines are expected to drive the segment.
- For instance, in February 2023, Arima Genomics, Inc., a 3D genomics company to reveal actionable insights, announced a partnership with Velsera, the precision engine company that enables the democratization of omic data across clinical and research applications. The partnership allows clinical laboratories to easily implement sample-to-answer Arima gene fusion testing and other structural variants.
Due to constant advancements, the magnetic resonance imaging (MRI) segment is predicted to increase at a rapid rate. Furthermore, it is estimated that the tools developed for visualizing diffusion-weighted MRI data would be used in microscopy applications. This is projected to boost the use of MRI in other procedures, as well as propel the biological data visualization market during the forecast period.
Application Segment Analysis
In terms of application, the market is segregated into cell & organism imaging, structural biology & molecular modeling, genomic analysis, alignments, phylogeny, & evolution, and systems biology. The cell and organism imaging segment is projected to dominate the market during the forecast period.
Developments in statistical analysis software, transmission electron microscope optics, and sensors that offer rapid readouts with the capacity to directly detect electrons have sped up the use of this technology. These developments are expected to drive the market.
Platform Segment Analysis
On the basis of platform, the market is categorized as Windows, MAC OS, Linux, and others. The windows segment is expected to increase at a rapid pace. Monitors, mice, graphics tablets, printers, keyboards, storage devices, scanners, and microphones are extremely compatible with Windows. Furthermore, this operating system is very compatible with all types of biological data visualization tools, making it popular among researchers and pharmaceutical businesses.
The MAC OS segment is expected to see lucrative growth during the forecast period due to increasing global MAC OS sales over the years. This operating system is easy to control and has a simple design compared to Windows. This is because Windows has multiple menu levels below the surface, which is not the case with MAC OS.
End-User Segment Analysis
In terms of end-user, the market is divided into academic research, hospitals & clinics, pharmaceutical & biotechnology companies, and others. The academic research segment is anticipated to dominate the market during the forecast period. Extensive use of sequencing and MRI methods in biomedical research, on-site bioinformatics courses, and workshops contribute to the estimated proportion.
Regional Analysis
Based on region, the market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market during the forecast period. The growth of capital-intensive biotech sectors, such as personalized medicine, and the development of high-throughput sequencing techniques are contributing a major share.
Segments
The global biological data visualization market has been segmented on the basis of
Techniques
- Microscopy
- Magnetic Resonance Imaging
- Sequencing
- X-ray Crystallography
- Others
Application
- Cell & Organism Imaging
- Structural Biology & Molecular Modeling
- Genomic Analysis
- Alignments, Phylogeny, & Evolution
- Systems Biology
Platform
- Windows
- Mac OS
- Linux
- Others
End-User
- Academic Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Region
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
- Thermo Fisher Scientific Inc
- Becton-Dickinson and Company
- QIAGEN
- Agilent Technologies, Inc
- 3M
- Carl Zeiss AG
- Oxford Instruments
- Olympus Corporation
- GE Healthcare
- Clarivate Analytics
- arivis AG
- Scientific Volume Imaging B.V
- Media Cybernetics, Inc
- Molecular Devices, LLC
- Danaher.
Competitive Landscape
Public market companies are making significant investments to enhance their footprint. Private companies, on the other hand, are utilizing agreement and collaboration methods to expand their product catalog and compete in the market. Key players in the market include Thermo Fisher Scientific Inc., QIAGEN, Becton-Dickinson and Company, Agilent Technologies, Inc., 3M, Carl Zeiss AG, Oxford Instruments, Olympus Corporation, GE Healthcare, Clarivate Analytics, arivis AG, Scientific Volume Imaging B.V., Media Cybernetics, Inc., Molecular Devices, LLC, and Danaher.
- In January 2021, Molecular Devices, LLC., a provider, in life science technology, has globally launched its next-generation, high-content imaging system. Built on the success of the company’s flagship model, the ImageXpress Confocal HT.ai High-Content Imaging System is designed to help researchers advance the phenotypic screening of 3D organoid models. The system provides faster image acquisition and multiplexing flexibility with high-performance lasers.
- In January 2021, Genedata, the provider of enterprise software solutions for biopharmaceutical R&D, released the Genedata Imagence® 3.0, the latest version of the deep learning-based software to automate the analysis of high-content screening (HCS) imaging data.
Frequently Asked Questions
The biological data visualization market was valued at USD 960.08 Million in 2022 and is expected to reach USD 2.10 Billion by 2031
The biological data visualization market is growing with a CAGR of 9.1%
The techniques segment accounts for the largest market share with the increasing demand for sequencing and magnetic resonance
The major players in the market include Thermo Fisher Scientific Inc., QIAGEN, Becton-Dickinson and Company, Agilent Technologies, Inc., 3M, Carl Zeiss AG, Oxford Instruments, Olympus Corporation, GE Healthcare, Clarivate Analytics, and others.
The rapid growth of big data is a factor driving the market.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Biological Data Visualization Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biological Data Visualization Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biological Data Visualization Market - Supply Chain
4.5. Global Biological Data Visualization Market Forecast
4.5.1. Biological Data Visualization Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biological Data Visualization Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Biological Data Visualization Market Absolute $ Opportunity
5. Global Biological Data Visualization Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Biological Data Visualization Market Size and Volume Forecast by Applications
5.3.1. Cell & Organism Imaging
5.3.2. Structural Biology & Molecular Modeling
5.3.3. Genomic Analysis
5.3.4. Alignments, Phylogeny, & Evolution
5.3.5. Systems Biology
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Biological Data Visualization Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Biological Data Visualization Market Size and Volume Forecast by End Users
6.3.1. Academic Research
6.3.2. Hospitals & Clinics
6.3.3. Pharmaceutical & Biotechnology Companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Biological Data Visualization Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Biological Data Visualization Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Biological Data Visualization Demand Share Forecast, 2019-2026
8. North America Biological Data Visualization Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Biological Data Visualization Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Biological Data Visualization Market Size and Volume Forecast by Applications
8.4.1. Cell & Organism Imaging
8.4.2. Structural Biology & Molecular Modeling
8.4.3. Genomic Analysis
8.4.4. Alignments, Phylogeny, & Evolution
8.4.5. Systems Biology
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Biological Data Visualization Market Size and Volume Forecast by End Users
8.7.1. Academic Research
8.7.2. Hospitals & Clinics
8.7.3. Pharmaceutical & Biotechnology Companies
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Biological Data Visualization Demand Share Forecast, 2019-2026
9. Latin America Biological Data Visualization Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Biological Data Visualization Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Biological Data Visualization Market Size and Volume Forecast by Applications
9.4.1. Cell & Organism Imaging
9.4.2. Structural Biology & Molecular Modeling
9.4.3. Genomic Analysis
9.4.4. Alignments, Phylogeny, & Evolution
9.4.5. Systems Biology
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Biological Data Visualization Market Size and Volume Forecast by End Users
9.7.1. Academic Research
9.7.2. Hospitals & Clinics
9.7.3. Pharmaceutical & Biotechnology Companies
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Biological Data Visualization Demand Share Forecast, 2019-2026
10. Europe Biological Data Visualization Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Biological Data Visualization Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Biological Data Visualization Market Size and Volume Forecast by Applications
10.4.1. Cell & Organism Imaging
10.4.2. Structural Biology & Molecular Modeling
10.4.3. Genomic Analysis
10.4.4. Alignments, Phylogeny, & Evolution
10.4.5. Systems Biology
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Biological Data Visualization Market Size and Volume Forecast by End Users
10.7.1. Academic Research
10.7.2. Hospitals & Clinics
10.7.3. Pharmaceutical & Biotechnology Companies
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Biological Data Visualization Demand Share Forecast, 2019-2026
11. Asia Pacific Biological Data Visualization Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Biological Data Visualization Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Biological Data Visualization Market Size and Volume Forecast by Applications
11.4.1. Cell & Organism Imaging
11.4.2. Structural Biology & Molecular Modeling
11.4.3. Genomic Analysis
11.4.4. Alignments, Phylogeny, & Evolution
11.4.5. Systems Biology
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Biological Data Visualization Market Size and Volume Forecast by End Users
11.7.1. Academic Research
11.7.2. Hospitals & Clinics
11.7.3. Pharmaceutical & Biotechnology Companies
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Biological Data Visualization Demand Share Forecast, 2019-2026
12. Middle East & Africa Biological Data Visualization Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Biological Data Visualization Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Biological Data Visualization Market Size and Volume Forecast by Applications
12.4.1. Cell & Organism Imaging
12.4.2. Structural Biology & Molecular Modeling
12.4.3. Genomic Analysis
12.4.4. Alignments, Phylogeny, & Evolution
12.4.5. Systems Biology
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Biological Data Visualization Market Size and Volume Forecast by End Users
12.7.1. Academic Research
12.7.2. Hospitals & Clinics
12.7.3. Pharmaceutical & Biotechnology Companies
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Biological Data Visualization Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Biological Data Visualization Market: Market Share Analysis
13.2. Biological Data Visualization Distributors and Customers
13.3. Biological Data Visualization Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Thermo Fisher Scientific Inc
13.4.2. QIAGEN
13.4.3. Becton-Dickinson and Company
13.4.4. Agilent Technologies, Inc
13.4.5. 3M
13.4.6. Carl Zeiss AG
13.4.7. Oxford Instruments
13.4.8. Olympus Corporation
13.4.9. GE Healthcare
13.4.10. Clarivate Analytics
13.4.11. arivis AG
13.4.12. Scientific Volume Imaging B.V
13.4.13. Media Cybernetics, Inc
13.4.14. Molecular Devices, LLC
13.4.15. Danaher
Methodology
Related Reports
Some other reports from this category!
Our Clients
